Glenmede Trust’s Maravai LifeSciences MRVI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,240,698
| Closed | -$12.2M | – | 1419 |
|
|
2024
Q4 | $12.2M | Buy |
2,240,698
+14,664
| +0.7% | +$79.9K | 0.06% | 326 |
|
|
2024
Q3 | $18.5M | Sell |
2,226,034
-31,853
| -1% | -$265K | 0.09% | 233 |
|
|
2024
Q2 | $16.2M | Buy |
2,257,887
+13,672
| +0.6% | +$97.9K | 0.08% | 251 |
|
|
2024
Q1 | $19.5M | Buy |
2,244,215
+161,287
| +8% | +$1.4M | 0.1% | 213 |
|
|
2023
Q4 | $13.6M | Buy |
2,082,928
+974,374
| +88% | +$6.38M | 0.07% | 289 |
|
|
2023
Q3 | $11.1M | Buy |
1,108,554
+688,403
| +164% | +$6.88M | 0.06% | 316 |
|
|
2023
Q2 | $5.81M | Buy |
420,151
+24,716
| +6% | +$342K | 0.03% | 396 |
|
|
2023
Q1 | $5.54M | Buy |
395,435
+369,903
| +1,449% | +$5.18M | 0.03% | 400 |
|
|
2022
Q4 | $365K | Buy |
25,532
+11,934
| +88% | +$171K | ﹤0.01% | 923 |
|
|
2022
Q3 | $347K | Sell |
13,598
-24,376
| -64% | -$622K | ﹤0.01% | 910 |
|
|
2022
Q2 | $1.08M | Buy |
+37,974
| New | +$1.08M | 0.01% | 654 |
|